

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | synaptic transmission, dopaminergic (GO:0001963) | 6.41504484 |
| 2 | prepulse inhibition (GO:0060134) | 6.34341290 |
| 3 | regulation of synapse structural plasticity (GO:0051823) | 6.24733108 |
| 4 | positive regulation of excitatory postsynaptic membrane potential (GO:2000463) | 5.78187625 |
| 5 | striatum development (GO:0021756) | 5.69886972 |
| 6 | adenylate cyclase-activating dopamine receptor signaling pathway (GO:0007191) | 5.47721767 |
| 7 | adenosine receptor signaling pathway (GO:0001973) | 5.45352901 |
| 8 | locomotory exploration behavior (GO:0035641) | 5.37532675 |
| 9 | membrane depolarization during cardiac muscle cell action potential (GO:0086012) | 5.09800779 |
| 10 | regulation of short-term neuronal synaptic plasticity (GO:0048172) | 5.06114069 |
| 11 | regulation of long-term neuronal synaptic plasticity (GO:0048169) | 4.96498644 |
| 12 | auditory behavior (GO:0031223) | 4.90354811 |
| 13 | negative regulation of cytosolic calcium ion concentration (GO:0051481) | 4.86887344 |
| 14 | response to amphetamine (GO:0001975) | 4.86850370 |
| 15 | synaptic vesicle maturation (GO:0016188) | 4.84538145 |
| 16 | regulation of alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionate selective glutamate receptor act | 4.83062954 |
| 17 | behavioral response to cocaine (GO:0048148) | 4.77646351 |
| 18 | vocalization behavior (GO:0071625) | 4.76467722 |
| 19 | positive regulation of synaptic transmission, glutamatergic (GO:0051968) | 4.71131168 |
| 20 | dopamine receptor signaling pathway (GO:0007212) | 4.68639396 |
| 21 | regulation of glutamate receptor signaling pathway (GO:1900449) | 4.66529656 |
| 22 | negative regulation of synaptic transmission, glutamatergic (GO:0051967) | 4.66471088 |
| 23 | neurotransmitter-gated ion channel clustering (GO:0072578) | 4.63188303 |
| 24 | detection of light stimulus involved in visual perception (GO:0050908) | 4.57277134 |
| 25 | detection of light stimulus involved in sensory perception (GO:0050962) | 4.57277134 |
| 26 | positive regulation of calcium ion-dependent exocytosis (GO:0045956) | 4.56858587 |
| 27 | regulation of neuronal synaptic plasticity (GO:0048168) | 4.51049608 |
| 28 | positive regulation of synaptic transmission, dopaminergic (GO:0032226) | 4.50312110 |
| 29 | regulation of dopamine uptake involved in synaptic transmission (GO:0051584) | 4.49587299 |
| 30 | regulation of catecholamine uptake involved in synaptic transmission (GO:0051940) | 4.49587299 |
| 31 | substrate-independent telencephalic tangential migration (GO:0021826) | 4.46164210 |
| 32 | substrate-independent telencephalic tangential interneuron migration (GO:0021843) | 4.46164210 |
| 33 | regulation of dendritic spine morphogenesis (GO:0061001) | 4.42187467 |
| 34 | positive regulation of synaptic transmission, GABAergic (GO:0032230) | 4.39076816 |
| 35 | neuron-neuron synaptic transmission (GO:0007270) | 4.31479126 |
| 36 | positive regulation of neurotransmitter transport (GO:0051590) | 4.28925445 |
| 37 | ionotropic glutamate receptor signaling pathway (GO:0035235) | 4.20996767 |
| 38 | response to auditory stimulus (GO:0010996) | 4.19549098 |
| 39 | neuromuscular process controlling balance (GO:0050885) | 4.18915842 |
| 40 | regulation of synaptic transmission, glutamatergic (GO:0051966) | 4.10421290 |
| 41 | regulation of inhibitory postsynaptic membrane potential (GO:0060080) | 4.07404014 |
| 42 | regulation of neurotransmitter uptake (GO:0051580) | 4.04246897 |
| 43 | G-protein coupled acetylcholine receptor signaling pathway (GO:0007213) | 4.03059140 |
| 44 | peristalsis (GO:0030432) | 4.02105872 |
| 45 | regulation of glutamate secretion (GO:0014048) | 4.01504019 |
| 46 | protein localization to synapse (GO:0035418) | 4.00491868 |
| 47 | regulation of excitatory postsynaptic membrane potential (GO:0060079) | 4.00071623 |
| 48 | synaptic vesicle exocytosis (GO:0016079) | 3.99755933 |
| 49 | phospholipase C-activating dopamine receptor signaling pathway (GO:0060158) | 3.97743550 |
| 50 | long-term memory (GO:0007616) | 3.97689866 |
| 51 | dendritic spine morphogenesis (GO:0060997) | 3.94913140 |
| 52 | synaptic transmission, glutamatergic (GO:0035249) | 3.94460461 |
| 53 | synaptic vesicle docking involved in exocytosis (GO:0016081) | 3.92120616 |
| 54 | regulation of synaptic vesicle exocytosis (GO:2000300) | 3.89010404 |
| 55 | transmission of nerve impulse (GO:0019226) | 3.87295758 |
| 56 | regulation of female receptivity (GO:0045924) | 3.84581462 |
| 57 | positive regulation of membrane potential (GO:0045838) | 3.83164794 |
| 58 | exploration behavior (GO:0035640) | 3.82137334 |
| 59 | neurotransmitter secretion (GO:0007269) | 3.80767124 |
| 60 | neuronal action potential propagation (GO:0019227) | 3.78935392 |
| 61 | presynaptic membrane assembly (GO:0097105) | 3.74624015 |
| 62 | behavioral response to nicotine (GO:0035095) | 3.74368716 |
| 63 | response to histamine (GO:0034776) | 3.72223535 |
| 64 | positive regulation of neurotransmitter secretion (GO:0001956) | 3.71946425 |
| 65 | visual learning (GO:0008542) | 3.70538937 |
| 66 | regulation of postsynaptic membrane potential (GO:0060078) | 3.69049599 |
| 67 | glutamate receptor signaling pathway (GO:0007215) | 3.68996485 |
| 68 | mechanosensory behavior (GO:0007638) | 3.66856738 |
| 69 | negative regulation of dendrite development (GO:2000171) | 3.61881297 |
| 70 | behavioral defense response (GO:0002209) | 3.59066954 |
| 71 | behavioral fear response (GO:0001662) | 3.59066954 |
| 72 | neuronal ion channel clustering (GO:0045161) | 3.57271571 |
| 73 | regulation of synaptic plasticity (GO:0048167) | 3.56961499 |
| 74 | activation of protein kinase A activity (GO:0034199) | 3.56275357 |
| 75 | regulation of N-methyl-D-aspartate selective glutamate receptor activity (GO:2000310) | 3.54574859 |
| 76 | postsynaptic membrane organization (GO:0001941) | 3.51494082 |
| 77 | layer formation in cerebral cortex (GO:0021819) | 3.51404175 |
| 78 | membrane hyperpolarization (GO:0060081) | 3.50426506 |
| 79 | * cAMP catabolic process (GO:0006198) | 3.49998666 |
| 80 | visual behavior (GO:0007632) | 3.49901005 |
| 81 | negative regulation of translation, ncRNA-mediated (GO:0040033) | 3.47254366 |
| 82 | regulation of translation, ncRNA-mediated (GO:0045974) | 3.47254366 |
| 83 | negative regulation of translation involved in gene silencing by miRNA (GO:0035278) | 3.47254366 |
| 84 | regulation of voltage-gated calcium channel activity (GO:1901385) | 3.46452603 |
| 85 | regulation of synaptic vesicle transport (GO:1902803) | 3.45632416 |
| 86 | establishment of protein localization to Golgi (GO:0072600) | 3.41726280 |
| 87 | gamma-aminobutyric acid transport (GO:0015812) | 3.41413055 |
| 88 | long-term synaptic potentiation (GO:0060291) | 3.40297575 |
| 89 | female mating behavior (GO:0060180) | 3.38887072 |
| 90 | response to amine (GO:0014075) | 3.37852651 |
| 91 | regulation of norepinephrine secretion (GO:0014061) | 3.35538450 |
| 92 | mating behavior (GO:0007617) | 3.35452850 |
| 93 | regulation of dendritic spine development (GO:0060998) | 3.35003022 |
| 94 | regulation of synaptic transmission, GABAergic (GO:0032228) | 3.33422392 |
| 95 | axonal fasciculation (GO:0007413) | 3.31225713 |
| 96 | neuron cell-cell adhesion (GO:0007158) | 3.30415099 |
| 97 | presynaptic membrane organization (GO:0097090) | 3.29767385 |
| 98 | neurological system process involved in regulation of systemic arterial blood pressure (GO:0001976) | 3.29382605 |
| 99 | regulation of Rap GTPase activity (GO:0032317) | 3.26327619 |
| 100 | cAMP biosynthetic process (GO:0006171) | 3.24843601 |
| 101 | learning (GO:0007612) | 3.23828392 |
| 102 | * cAMP metabolic process (GO:0046058) | 3.23002508 |
| 103 | regulation of synaptic transmission, dopaminergic (GO:0032225) | 3.22310014 |
| 104 | calcium ion import (GO:0070509) | 3.19738375 |
| 105 | membrane depolarization (GO:0051899) | 3.19723047 |
| 106 | fear response (GO:0042596) | 3.17657622 |
| 107 | dendrite morphogenesis (GO:0048813) | 3.17541852 |
| 108 | membrane depolarization during action potential (GO:0086010) | 3.17093855 |
| 109 | glutamate secretion (GO:0014047) | 3.15868927 |
| 110 | negative regulation of amino acid transport (GO:0051956) | 3.14512420 |
| 111 | drinking behavior (GO:0042756) | 3.13119198 |
| 112 | protein polyglutamylation (GO:0018095) | 3.11077312 |
| 113 | neuromuscular process (GO:0050905) | 3.10846603 |
| 114 | positive regulation of synaptic transmission (GO:0050806) | 3.09026608 |
| 115 | central nervous system projection neuron axonogenesis (GO:0021952) | 3.04601255 |
| 116 | * cyclic nucleotide catabolic process (GO:0009214) | 3.01782581 |
| 117 | protein targeting to Golgi (GO:0000042) | 3.00610487 |
| 118 | pyrimidine nucleobase catabolic process (GO:0006208) | 2.91268614 |
| 119 | limb development (GO:0060173) | 2.90959432 |
| 120 | appendage development (GO:0048736) | 2.90959432 |
| 121 | central nervous system neuron axonogenesis (GO:0021955) | 2.87455734 |
| 122 | G-protein coupled glutamate receptor signaling pathway (GO:0007216) | 2.87147165 |
| 123 | neuron recognition (GO:0008038) | 2.86557055 |
| 124 | retrograde transport, vesicle recycling within Golgi (GO:0000301) | 2.84594768 |
| 125 | cellular response to sterol (GO:0036315) | 2.80951686 |
| 126 | alanine transport (GO:0032328) | 2.69167700 |
| 127 | artery development (GO:0060840) | 2.68126233 |
| 128 | proline transport (GO:0015824) | 2.67055594 |
| 129 | regulation of cilium movement (GO:0003352) | 2.66037580 |
| 130 | cellular response to cholesterol (GO:0071397) | 2.61967515 |
| 131 | protein localization to Golgi apparatus (GO:0034067) | 2.59011147 |
| 132 | cochlea development (GO:0090102) | 2.57817001 |
| 133 | response to pheromone (GO:0019236) | 2.55888619 |
| 134 | microtubule severing (GO:0051013) | 2.55857066 |
| 135 | cranial nerve morphogenesis (GO:0021602) | 2.55674122 |
| 136 | limb bud formation (GO:0060174) | 2.54241948 |
| 137 | negative regulation of axon guidance (GO:1902668) | 2.53747819 |
| 138 | establishment of nucleus localization (GO:0040023) | 2.52233858 |
| 139 | neuromuscular synaptic transmission (GO:0007274) | 2.48425400 |
| 140 | nucleobase catabolic process (GO:0046113) | 2.47869581 |
| 141 | retinal ganglion cell axon guidance (GO:0031290) | 2.47045897 |
| 142 | sperm motility (GO:0030317) | 2.46087435 |
| 143 | inner ear receptor stereocilium organization (GO:0060122) | 2.45186833 |
| 144 | somite rostral/caudal axis specification (GO:0032525) | 2.44489296 |
| 145 | synapse assembly (GO:0007416) | 2.43496417 |
| 146 | regulation of hippo signaling (GO:0035330) | 2.43429402 |
| 147 | regulation of sarcomere organization (GO:0060297) | 2.40439526 |
| 148 | negative regulation of axon extension involved in axon guidance (GO:0048843) | 2.37220786 |
| 149 | regulation of axon guidance (GO:1902667) | 2.36280499 |
| 150 | negative regulation of synaptic transmission, GABAergic (GO:0032229) | 2.35380739 |
| 151 | retina layer formation (GO:0010842) | 2.35316357 |
| 152 | nonmotile primary cilium assembly (GO:0035058) | 2.34946756 |
| 153 | regulation of action potential (GO:0098900) | 2.33700082 |
| 154 | L-fucose catabolic process (GO:0042355) | 2.32823314 |
| 155 | fucose catabolic process (GO:0019317) | 2.32823314 |
| 156 | L-fucose metabolic process (GO:0042354) | 2.32823314 |
| 157 | C4-dicarboxylate transport (GO:0015740) | 2.32008940 |
| 158 | intraciliary transport (GO:0042073) | 2.30871546 |
| 159 | acrosome reaction (GO:0007340) | 2.27466193 |
| 160 | cell migration in hindbrain (GO:0021535) | 2.26631062 |
| 161 | urinary tract smooth muscle contraction (GO:0014848) | 2.26559481 |
| 162 | dendrite development (GO:0016358) | 2.26463765 |
| 163 | acrosome assembly (GO:0001675) | 2.24956780 |
| 164 | spinal cord motor neuron differentiation (GO:0021522) | 2.24747033 |
| 165 | spinal cord development (GO:0021510) | 2.24550527 |
| 166 | regulation of axon extension involved in axon guidance (GO:0048841) | 2.24035303 |
| 167 | head development (GO:0060322) | 2.22616193 |
| 168 | sympathetic nervous system development (GO:0048485) | 2.21667364 |
| 169 | somite development (GO:0061053) | 2.21376144 |
| 170 | axonogenesis (GO:0007409) | 2.18290826 |
| 171 | tachykinin receptor signaling pathway (GO:0007217) | 2.17003487 |
| 172 | cAMP-mediated signaling (GO:0019933) | 2.16213908 |
| 173 | startle response (GO:0001964) | 2.14792566 |
| 174 | reflex (GO:0060004) | 2.14568134 |
| 175 | gamma-aminobutyric acid signaling pathway (GO:0007214) | 2.13736146 |
| 176 | cilium assembly (GO:0042384) | 2.13350058 |
| 177 | prostate epithelial cord arborization involved in prostate glandular acinus morphogenesis (GO:006052 | 2.12674156 |
| 178 | synapse organization (GO:0050808) | 2.12354692 |
| 179 | cilium organization (GO:0044782) | 2.12320285 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | EZH2_22144423_ChIP-Seq_EOC_Human | 5.03340527 |
| 2 | * RARB_27405468_Chip-Seq_BRAIN_Mouse | 3.89331505 |
| 3 | GBX2_23144817_ChIP-Seq_PC3_Human | 3.44183228 |
| 4 | * SUZ12_18692474_ChIP-Seq_MESCs_Mouse | 3.11722333 |
| 5 | * SUZ12_18555785_ChIP-Seq_MESCs_Mouse | 3.05874362 |
| 6 | * JARID2_20064375_ChIP-Seq_MESCs_Mouse | 2.93302270 |
| 7 | DROSHA_22980978_ChIP-Seq_HELA_Human | 2.84565219 |
| 8 | MYCN_19997598_ChIP-ChIP_NEUROBLASTOMA_Human | 2.77760491 |
| 9 | * JARID2_20075857_ChIP-Seq_MESCs_Mouse | 2.66132131 |
| 10 | * EZH2_18974828_ChIP-Seq_MESCs_Mouse | 2.66081500 |
| 11 | * RNF2_18974828_ChIP-Seq_MESCs_Mouse | 2.66081500 |
| 12 | REST_21632747_ChIP-Seq_MESCs_Mouse | 2.64302667 |
| 13 | * SUZ12_18974828_ChIP-Seq_MESCs_Mouse | 2.58876812 |
| 14 | * MTF2_20144788_ChIP-Seq_MESCs_Mouse | 2.54554637 |
| 15 | * SUZ12_20075857_ChIP-Seq_MESCs_Mouse | 2.54397835 |
| 16 | * SUZ12_18692474_ChIP-Seq_MEFs_Mouse | 2.51358569 |
| 17 | * EZH2_27304074_Chip-Seq_ESCs_Mouse | 2.41134845 |
| 18 | FUS_26573619_Chip-Seq_HEK293_Human | 2.36787133 |
| 19 | ZFP322A_24550733_ChIP-Seq_MESCs_Mouse | 2.28091882 |
| 20 | * CBX2_27304074_Chip-Seq_ESCs_Mouse | 2.27954312 |
| 21 | EZH2_23942234_ChIP-Seq_MYOBLASTS_AND_MYOTUBES_Mouse | 2.27036142 |
| 22 | * SUZ12_27294783_Chip-Seq_ESCs_Mouse | 2.24874403 |
| 23 | SUZ12_16625203_ChIP-ChIP_MESCs_Mouse | 2.22738189 |
| 24 | * EZH2_27294783_Chip-Seq_ESCs_Mouse | 2.20671660 |
| 25 | REST_18959480_ChIP-ChIP_MESCs_Mouse | 2.17258658 |
| 26 | RNF2_27304074_Chip-Seq_ESCs_Mouse | 2.17134554 |
| 27 | AR_21572438_ChIP-Seq_LNCaP_Human | 2.13907729 |
| 28 | * POU3F2_20337985_ChIP-ChIP_501MEL_Human | 2.11261770 |
| 29 | IKZF1_21737484_ChIP-ChIP_HCT116_Human | 2.07968058 |
| 30 | CEBPD_23245923_ChIP-Seq_MEFs_Mouse | 2.05256034 |
| 31 | FOXP1_22492998_ChIP-Seq_STRATIUM_Mouse | 1.92845451 |
| 32 | EED_16625203_ChIP-ChIP_MESCs_Mouse | 1.92812487 |
| 33 | IGF1R_20145208_ChIP-Seq_DFB_Human | 1.87590645 |
| 34 | ERG_21242973_ChIP-ChIP_JURKAT_Human | 1.86721350 |
| 35 | VDR_22108803_ChIP-Seq_LS180_Human | 1.86216820 |
| 36 | SALL1_21062744_ChIP-ChIP_HESCs_Human | 1.84803433 |
| 37 | BMI1_23680149_ChIP-Seq_NPCS_Mouse | 1.77069289 |
| 38 | SMARCD1_25818293_ChIP-Seq_ESCs_Mouse | 1.68226776 |
| 39 | * RNF2_27304074_Chip-Seq_NSC_Mouse | 1.67342506 |
| 40 | CDKN2AIP_20523734_ChIP-Seq_CORTICAL_Neurons | 1.63487046 |
| 41 | BCL11B_21912641_ChIP-Seq_STHDH_STRIUM_Mouse | 1.63099038 |
| 42 | NR4A2_19515692_ChIP-ChIP_MN9D_Mouse | 1.60548144 |
| 43 | CTBP2_25329375_ChIP-Seq_LNCAP_Human | 1.57270541 |
| 44 | TAL1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 1.56427684 |
| 45 | PRDM16_22522345_ChIP-ChIP_PALATE_MESENCHYMAL_Mouse | 1.56303086 |
| 46 | GLI1_17442700_ChIP-ChIP_MESCs_Mouse | 1.56111423 |
| 47 | EWS_26573619_Chip-Seq_HEK293_Human | 1.53910377 |
| 48 | GATA2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.52294876 |
| 49 | TAL1_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.45646397 |
| 50 | * SMAD4_21799915_ChIP-Seq_A2780_Human | 1.44688255 |
| 51 | TEAD4_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.44384534 |
| 52 | POU5F1_26923725_Chip-Seq_MESODERM_Mouse | 1.44384534 |
| 53 | TAF15_26573619_Chip-Seq_HEK293_Human | 1.42898935 |
| 54 | BCAT_22108803_ChIP-Seq_LS180_Human | 1.41662225 |
| 55 | DNAJC2_21179169_ChIP-ChIP_NT2_Human | 1.36895516 |
| 56 | * MEIS1_26253404_ChIP-Seq_OPTIC_CUPS_Mouse | 1.36593644 |
| 57 | UBF1/2_26484160_Chip-Seq_FIBROBLAST_Human | 1.36171094 |
| 58 | * SMAD2/3_21741376_ChIP-Seq_EPCs_Human | 1.35777812 |
| 59 | * WT1_25993318_ChIP-Seq_PODOCYTE_Human | 1.33679818 |
| 60 | IRF4_20064451_ChIP-Seq_CD4+T_Mouse | 1.32822875 |
| 61 | CBP_20019798_ChIP-Seq_JUKART_Human | 1.32822875 |
| 62 | RCOR3_21632747_ChIP-Seq_MESCs_Mouse | 1.32068513 |
| 63 | SOX2_21211035_ChIP-Seq_LN229_Gbm | 1.30673771 |
| 64 | KDM2B_26808549_Chip-Seq_K562_Human | 1.29952245 |
| 65 | * SMAD3_21741376_ChIP-Seq_EPCs_Human | 1.29909037 |
| 66 | ER_23166858_ChIP-Seq_MCF-7_Human | 1.27631037 |
| 67 | TFAP2C_20629094_ChIP-Seq_MCF-7_Human | 1.27474232 |
| 68 | RUNX1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 1.27064519 |
| 69 | STAT3_23295773_ChIP-Seq_U87_Human | 1.26880639 |
| 70 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 1.26262583 |
| 71 | RBPJ_22232070_ChIP-Seq_NCS_Mouse | 1.26198716 |
| 72 | P53_22127205_ChIP-Seq_FIBROBLAST_Human | 1.26184284 |
| 73 | CTBP1_25329375_ChIP-Seq_LNCAP_Human | 1.25860661 |
| 74 | * PAX3-FKHR_20663909_ChIP-Seq_RHABDOMYOSARCOMA_Human | 1.25664571 |
| 75 | RING1B_27294783_Chip-Seq_ESCs_Mouse | 1.25085957 |
| 76 | ZNF217_24962896_ChIP-Seq_MCF-7_Human | 1.24903336 |
| 77 | * AR_19668381_ChIP-Seq_PC3_Human | 1.23878389 |
| 78 | * WT1_20215353_ChIP-ChIP_NEPHRON_PROGENITOR_Mouse | 1.19975450 |
| 79 | * EGR1_20690147_ChIP-Seq_ERYTHROLEUKEMIA_Human | 1.17547117 |
| 80 | CTNNB1_20615089_ChIP-ChIP_FETAL_BRAIN_Human | 1.14543062 |
| 81 | NR3C1_23031785_ChIP-Seq_PC12_Mouse | 1.13952533 |
| 82 | CEBPB_26923725_Chip-Seq_MESODERM_Mouse | 1.13708500 |
| 83 | * TEAD4_22529382_ChIP-Seq_TROPHECTODERM_Mouse | 1.13594988 |
| 84 | GATA2_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.13149737 |
| 85 | SMAD4_21741376_ChIP-Seq_EPCs_Human | 1.12844600 |
| 86 | TCFCP2L1_18555785_Chip-Seq_ESCs_Mouse | 1.11830375 |
| 87 | P300_19829295_ChIP-Seq_ESCs_Human | 1.11608600 |
| 88 | CEBPB_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.11452823 |
| 89 | * RING1B_27294783_Chip-Seq_NPCs_Mouse | 1.10829308 |
| 90 | AHR_22903824_ChIP-Seq_MCF-7_Human | 1.10627045 |
| 91 | TCF4_22108803_ChIP-Seq_LS180_Human | 1.09807096 |
| 92 | TP53_18474530_ChIP-ChIP_U2OS_Human | 1.09459076 |
| 93 | NANOG_18555785_Chip-Seq_ESCs_Mouse | 1.09304710 |
| 94 | TCF3/E2A_22897851_ChIP-Seq_JUKARTE6-1_Human | 1.08730666 |
| 95 | TBL1_22424771_ChIP-Seq_293T_Human | 1.08634380 |
| 96 | STAT3_24763339_ChIP-Seq_IMN-ESCs_Mouse | 1.08417236 |
| 97 | ZFP281_18757296_ChIP-ChIP_E14_Mouse | 1.08343408 |
| 98 | * TCF4_23295773_ChIP-Seq_U87_Human | 1.06598071 |
| 99 | ZFP57_27257070_Chip-Seq_ESCs_Mouse | 1.05970205 |
| 100 | KLF4_25985364_ChIP-Seq_ATHEROSCLEROSIS_LESION_Mouse | 1.04815065 |
| 101 | LMO2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.03985840 |
| 102 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 1.03566114 |
| 103 | * SMAD3_21741376_ChIP-Seq_HESCs_Human | 1.03155633 |
| 104 | MYC_20876797_ChIP-ChIP_MEDULLOBLASTOMA_Human | 1.02368275 |
| 105 | CTCF_27219007_Chip-Seq_Bcells_Human | 1.01432051 |
| 106 | * KDM2B_26808549_Chip-Seq_REH_Human | 1.01294936 |
| 107 | MEIS1_26923725_Chip-Seq_HEMOGENIC-ENDOTHELIUM_Mouse | 1.01249329 |
| 108 | AR_25329375_ChIP-Seq_VCAP_Human | 1.00912818 |
| 109 | PHC1_16625203_ChIP-ChIP_MESCs_Mouse | 1.00709342 |
| 110 | SOX9_26525672_Chip-Seq_HEART_Mouse | 1.00664983 |
| 111 | OLIG2_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 1.00288314 |
| 112 | * YAP1_20516196_ChIP-Seq_MESCs_Mouse | 1.00230501 |
| 113 | SCL_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.98806038 |
| 114 | ARNT_22903824_ChIP-Seq_MCF-7_Human | 0.98621455 |
| 115 | RUNX2_22187159_ChIP-Seq_PCA_Human | 0.96941273 |
| 116 | RXR_22108803_ChIP-Seq_LS180_Human | 0.96496646 |
| 117 | SMARCA4_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 0.96450098 |
| 118 | ESR1_20079471_ChIP-ChIP_T-47D_Human | 0.95698512 |
| 119 | TOP2B_26459242_ChIP-Seq_MCF-7_Human | 0.95414564 |
| 120 | ZFP281_27345836_Chip-Seq_ESCs_Mouse | 0.94341810 |
| 121 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 0.94152012 |
| 122 | * ESR1_22446102_ChIP-Seq_UTERUS_Mouse | 0.93017345 |
| 123 | * AR_22383394_ChIP-Seq_PROSTATE_CANCER_Human | 0.92886477 |
| 124 | SMAD3_22036565_ChIP-Seq_ESCs_Mouse | 0.92775125 |
| 125 | TP53_16413492_ChIP-PET_HCT116_Human | 0.92708554 |
| 126 | NR3C1_21868756_ChIP-Seq_MCF10A_Human | 0.92639630 |
| 127 | SMAD3_21741376_ChIP-Seq_ESCs_Human | 0.92133340 |
| 128 | PIAS1_25552417_ChIP-Seq_VCAP_Human | 0.91849655 |
| 129 | RNF2_16625203_ChIP-ChIP_MESCs_Mouse | 0.91346270 |
| 130 | TCF3_18467660_ChIP-ChIP_MESCs_Mouse | 0.90332695 |
| 131 | RCOR2_21632747_ChIP-Seq_MESCs_Mouse | 0.90073857 |
| 132 | GATA1_26923725_Chip-Seq_HPCs_Mouse | 0.89898455 |
| 133 | * SMAD4_21741376_ChIP-Seq_HESCs_Human | 0.89562518 |
| 134 | ESRRB_18555785_ChIP-Seq_MESCs_Mouse | 0.89388587 |
| 135 | * KLF4_19829295_ChIP-Seq_ESCs_Human | 0.88057994 |
| 136 | ZNF274_21170338_ChIP-Seq_K562_Hela | 0.87876139 |
| 137 | TET1_21490601_ChIP-Seq_MESCs_Mouse | 0.86603825 |
| 138 | PRDM14_20953172_ChIP-Seq_ESCs_Human | 0.86138569 |
| 139 | * DMRT1_23473982_ChIP-Seq_TESTES_Mouse | 0.85600324 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0002822_catalepsy | 9.60708673 |
| 2 | MP0004859_abnormal_synaptic_plasticity | 6.12809234 |
| 3 | MP0003880_abnormal_central_pattern | 4.02096733 |
| 4 | MP0003635_abnormal_synaptic_transmissio | 4.01999300 |
| 5 | MP0009745_abnormal_behavioral_response | 3.69076360 |
| 6 | * MP0002063_abnormal_learning/memory/cond | 3.39029967 |
| 7 | MP0004270_analgesia | 3.27099567 |
| 8 | MP0001529_abnormal_vocalization | 2.98267036 |
| 9 | MP0002064_seizures | 2.91274817 |
| 10 | MP0009046_muscle_twitch | 2.85572725 |
| 11 | MP0001486_abnormal_startle_reflex | 2.75409059 |
| 12 | * MP0002572_abnormal_emotion/affect_behav | 2.70925856 |
| 13 | MP0002909_abnormal_adrenal_gland | 2.57285772 |
| 14 | MP0002272_abnormal_nervous_system | 2.45668287 |
| 15 | MP0001968_abnormal_touch/_nociception | 2.44944269 |
| 16 | MP0005423_abnormal_somatic_nervous | 2.30769179 |
| 17 | MP0005646_abnormal_pituitary_gland | 2.25140211 |
| 18 | MP0003136_yellow_coat_color | 2.14265127 |
| 19 | MP0002638_abnormal_pupillary_reflex | 2.09755259 |
| 20 | MP0005409_darkened_coat_color | 2.05629688 |
| 21 | MP0002734_abnormal_mechanical_nocicepti | 2.05031995 |
| 22 | MP0004924_abnormal_behavior | 2.01581120 |
| 23 | MP0005386_behavior/neurological_phenoty | 2.01581120 |
| 24 | MP0001501_abnormal_sleep_pattern | 1.97999760 |
| 25 | MP0002234_abnormal_pharynx_morphology | 1.94567164 |
| 26 | MP0000566_synostosis | 1.93773289 |
| 27 | MP0001188_hyperpigmentation | 1.79776865 |
| 28 | MP0008569_lethality_at_weaning | 1.72110010 |
| 29 | MP0001970_abnormal_pain_threshold | 1.69479036 |
| 30 | MP0000049_abnormal_middle_ear | 1.67658087 |
| 31 | MP0002733_abnormal_thermal_nociception | 1.66450627 |
| 32 | MP0004811_abnormal_neuron_physiology | 1.65729955 |
| 33 | MP0001984_abnormal_olfaction | 1.62388164 |
| 34 | MP0002736_abnormal_nociception_after | 1.58138217 |
| 35 | * MP0002557_abnormal_social/conspecific_i | 1.55714821 |
| 36 | MP0001440_abnormal_grooming_behavior | 1.55663305 |
| 37 | MP0006292_abnormal_olfactory_placode | 1.55625903 |
| 38 | MP0009780_abnormal_chondrocyte_physiolo | 1.54047014 |
| 39 | MP0003937_abnormal_limbs/digits/tail_de | 1.51418969 |
| 40 | MP0002067_abnormal_sensory_capabilities | 1.50481332 |
| 41 | MP0004133_heterotaxia | 1.50450051 |
| 42 | MP0000026_abnormal_inner_ear | 1.48117186 |
| 43 | MP0002938_white_spotting | 1.45439901 |
| 44 | MP0005253_abnormal_eye_physiology | 1.42491301 |
| 45 | MP0003119_abnormal_digestive_system | 1.36075280 |
| 46 | MP0003879_abnormal_hair_cell | 1.33784927 |
| 47 | MP0004885_abnormal_endolymph | 1.33113687 |
| 48 | MP0002735_abnormal_chemical_nociception | 1.32970650 |
| 49 | MP0003633_abnormal_nervous_system | 1.31728141 |
| 50 | MP0010030_abnormal_orbit_morphology | 1.31513652 |
| 51 | MP0001177_atelectasis | 1.30932442 |
| 52 | MP0002184_abnormal_innervation | 1.27521589 |
| 53 | MP0008874_decreased_physiological_sensi | 1.26935938 |
| 54 | MP0003075_altered_response_to | 1.26128938 |
| 55 | * MP0002066_abnormal_motor_capabilities/c | 1.24465978 |
| 56 | MP0001905_abnormal_dopamine_level | 1.23630655 |
| 57 | MP0002102_abnormal_ear_morphology | 1.23271737 |
| 58 | MP0000955_abnormal_spinal_cord | 1.22782676 |
| 59 | MP0000569_abnormal_digit_pigmentation | 1.22131459 |
| 60 | MP0000534_abnormal_ureter_morphology | 1.22080435 |
| 61 | MP0008872_abnormal_physiological_respon | 1.20435878 |
| 62 | MP0000013_abnormal_adipose_tissue | 1.15690663 |
| 63 | MP0005167_abnormal_blood-brain_barrier | 1.15328908 |
| 64 | MP0003755_abnormal_palate_morphology | 1.14967339 |
| 65 | MP0000778_abnormal_nervous_system | 1.14369640 |
| 66 | MP0003938_abnormal_ear_development | 1.13345357 |
| 67 | MP0002751_abnormal_autonomic_nervous | 1.13340690 |
| 68 | MP0002233_abnormal_nose_morphology | 1.13033850 |
| 69 | MP0009250_abnormal_appendicular_skeleto | 1.12834113 |
| 70 | MP0003861_abnormal_nervous_system | 1.12070129 |
| 71 | MP0003329_amyloid_beta_deposits | 1.12051711 |
| 72 | MP0006072_abnormal_retinal_apoptosis | 1.10975279 |
| 73 | MP0002882_abnormal_neuron_morphology | 1.10502561 |
| 74 | MP0005187_abnormal_penis_morphology | 1.10407569 |
| 75 | MP0005195_abnormal_posterior_eye | 1.08681972 |
| 76 | MP0001286_abnormal_eye_development | 1.06004566 |
| 77 | MP0004085_abnormal_heartbeat | 1.05632062 |
| 78 | MP0003942_abnormal_urinary_system | 1.04919650 |
| 79 | MP0005410_abnormal_fertilization | 1.02805383 |
| 80 | MP0005391_vision/eye_phenotype | 1.02483448 |
| 81 | MP0004858_abnormal_nervous_system | 1.01718049 |
| 82 | MP0003631_nervous_system_phenotype | 1.01323074 |
| 83 | MP0004145_abnormal_muscle_electrophysio | 1.00616057 |
| 84 | MP0003890_abnormal_embryonic-extraembry | 0.99810062 |
| 85 | MP0003283_abnormal_digestive_organ | 0.99757391 |
| 86 | MP0002697_abnormal_eye_size | 0.99423944 |
| 87 | MP0008961_abnormal_basal_metabolism | 0.98933701 |
| 88 | MP0002932_abnormal_joint_morphology | 0.97813080 |
| 89 | MP0005171_absent_coat_pigmentation | 0.97270295 |
| 90 | MP0003385_abnormal_body_wall | 0.96089758 |
| 91 | MP0000383_abnormal_hair_follicle | 0.95207631 |
| 92 | MP0003935_abnormal_craniofacial_develop | 0.93116125 |
| 93 | MP0005367_renal/urinary_system_phenotyp | 0.92551959 |
| 94 | MP0000516_abnormal_urinary_system | 0.92551959 |
| 95 | MP0003690_abnormal_glial_cell | 0.92457004 |
| 96 | MP0003698_abnormal_male_reproductive | 0.92411856 |
| 97 | MP0004215_abnormal_myocardial_fiber | 0.91713500 |
| 98 | MP0000537_abnormal_urethra_morphology | 0.91284845 |
| 99 | MP0002069_abnormal_eating/drinking_beha | 0.90717360 |
| 100 | MP0002249_abnormal_larynx_morphology | 0.90424528 |
| 101 | MP0001502_abnormal_circadian_rhythm | 0.90081416 |
| 102 | MP0002152_abnormal_brain_morphology | 0.89767334 |
| 103 | MP0001293_anophthalmia | 0.89434100 |
| 104 | MP0002090_abnormal_vision | 0.89212739 |
| 105 | MP0010234_abnormal_vibrissa_follicle | 0.88968087 |
| 106 | MP0005535_abnormal_body_temperature | 0.86336907 |
| 107 | MP0000428_abnormal_craniofacial_morphol | 0.86304580 |
| 108 | MP0008789_abnormal_olfactory_epithelium | 0.85241029 |
| 109 | MP0002116_abnormal_craniofacial_bone | 0.82710711 |
| 110 | MP0005645_abnormal_hypothalamus_physiol | 0.82642208 |
| 111 | MP0003787_abnormal_imprinting | 0.82454014 |
| 112 | MP0004142_abnormal_muscle_tone | 0.80409547 |
| 113 | MP0000920_abnormal_myelination | 0.80029435 |
| 114 | MP0000631_abnormal_neuroendocrine_gland | 0.73039588 |
| 115 | MP0002229_neurodegeneration | 0.72796096 |
| 116 | MP0005394_taste/olfaction_phenotype | 0.71940749 |
| 117 | MP0005499_abnormal_olfactory_system | 0.71940749 |
| 118 | MP0003137_abnormal_impulse_conducting | 0.70385010 |
| 119 | MP0000751_myopathy | 0.68177045 |
| 120 | MP0003634_abnormal_glial_cell | 0.64552304 |
| 121 | MP0006276_abnormal_autonomic_nervous | 0.64120335 |
| 122 | MP0004742_abnormal_vestibular_system | 0.56372519 |
| 123 | MP0004043_abnormal_pH_regulation | 0.56175184 |
| 124 | MP0001485_abnormal_pinna_reflex | 0.55034501 |
| 125 | MP0001664_abnormal_digestion | 0.54487008 |
| 126 | MP0003632_abnormal_nervous_system | 0.54242141 |
| 127 | MP0005551_abnormal_eye_electrophysiolog | 0.53893177 |
| 128 | MP0001943_abnormal_respiration | 0.47743836 |
| 129 | MP0000604_amyloidosis | 0.45499137 |
| 130 | MP0005166_decreased_susceptibility_to | 0.45151769 |
| 131 | MP0001299_abnormal_eye_distance/ | 0.43978241 |
| 132 | * MP0003956_abnormal_body_size | 0.43096858 |
| 133 | MP0002752_abnormal_somatic_nervous | 0.41399201 |
| 134 | MP0000003_abnormal_adipose_tissue | 0.41367291 |
| 135 | MP0010769_abnormal_survival | 0.40351148 |
| 136 | MP0005620_abnormal_muscle_contractility | 0.39840997 |
| 137 | MP0010770_preweaning_lethality | 0.38801785 |
| 138 | MP0002082_postnatal_lethality | 0.38801785 |
| 139 | MP0010768_mortality/aging | 0.37290492 |
| 140 | MP0003122_maternal_imprinting | 0.37217988 |
| 141 | MP0001963_abnormal_hearing_physiology | 0.37205163 |
| 142 | MP0000230_abnormal_systemic_arterial | 0.37164119 |
| 143 | MP0001765_abnormal_ion_homeostasis | 0.35925206 |
| 144 | MP0010386_abnormal_urinary_bladder | 0.35803595 |
| 145 | MP0004036_abnormal_muscle_relaxation | 0.35292103 |
| 146 | MP0004233_abnormal_muscle_weight | 0.34308425 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Myokymia (HP:0002411) | 9.70761517 |
| 2 | Focal motor seizures (HP:0011153) | 7.77036797 |
| 3 | Congenital stationary night blindness (HP:0007642) | 5.83270932 |
| 4 | Focal seizures (HP:0007359) | 5.68602953 |
| 5 | Abnormality of macular pigmentation (HP:0008002) | 5.19708422 |
| 6 | Severe visual impairment (HP:0001141) | 5.07090226 |
| 7 | Resting tremor (HP:0002322) | 4.88224263 |
| 8 | Hypoplasia of the fovea (HP:0007750) | 4.55853096 |
| 9 | Aplasia/Hypoplasia of the fovea (HP:0008060) | 4.55853096 |
| 10 | Torticollis (HP:0000473) | 4.55491058 |
| 11 | Central scotoma (HP:0000603) | 4.53005901 |
| 12 | Annular pancreas (HP:0001734) | 4.42264750 |
| 13 | Action tremor (HP:0002345) | 4.36276856 |
| 14 | Abnormal rod and cone electroretinograms (HP:0008323) | 4.17762698 |
| 15 | Poor eye contact (HP:0000817) | 4.14427970 |
| 16 | Visual hallucinations (HP:0002367) | 3.93998036 |
| 17 | Focal dystonia (HP:0004373) | 3.87695832 |
| 18 | Broad-based gait (HP:0002136) | 3.87656809 |
| 19 | Anxiety (HP:0000739) | 3.85067654 |
| 20 | Ankle clonus (HP:0011448) | 3.83688621 |
| 21 | Craniofacial dystonia (HP:0012179) | 3.83240587 |
| 22 | Dysdiadochokinesis (HP:0002075) | 3.79663372 |
| 23 | Abnormality of the fovea (HP:0000493) | 3.77370075 |
| 24 | Abnormal social behavior (HP:0012433) | 3.74878265 |
| 25 | Impaired social interactions (HP:0000735) | 3.74878265 |
| 26 | Impaired vibration sensation in the lower limbs (HP:0002166) | 3.68726889 |
| 27 | Gaze-evoked nystagmus (HP:0000640) | 3.65408381 |
| 28 | Scanning speech (HP:0002168) | 3.59351863 |
| 29 | Ankyloglossia (HP:0010296) | 3.57036764 |
| 30 | Depression (HP:0000716) | 3.56905950 |
| 31 | Dysmetric saccades (HP:0000641) | 3.52450675 |
| 32 | Epileptic encephalopathy (HP:0200134) | 3.50075251 |
| 33 | Urinary bladder sphincter dysfunction (HP:0002839) | 3.39226018 |
| 34 | Febrile seizures (HP:0002373) | 3.35756920 |
| 35 | Generalized tonic-clonic seizures (HP:0002069) | 3.33961923 |
| 36 | Prolonged QT interval (HP:0001657) | 3.25271471 |
| 37 | Stereotypic behavior (HP:0000733) | 3.17611737 |
| 38 | Absence seizures (HP:0002121) | 3.17311593 |
| 39 | Truncal ataxia (HP:0002078) | 3.09273530 |
| 40 | Dysmetria (HP:0001310) | 3.06236658 |
| 41 | Urinary urgency (HP:0000012) | 3.03829898 |
| 42 | Progressive cerebellar ataxia (HP:0002073) | 3.02292125 |
| 43 | Scotoma (HP:0000575) | 3.01330492 |
| 44 | Dialeptic seizures (HP:0011146) | 3.00715256 |
| 45 | Impaired smooth pursuit (HP:0007772) | 2.98396430 |
| 46 | Lower limb amyotrophy (HP:0007210) | 2.97659973 |
| 47 | Pointed chin (HP:0000307) | 2.97358941 |
| 48 | Postural instability (HP:0002172) | 2.94006787 |
| 49 | Aplasia/Hypoplasia of the macula (HP:0008059) | 2.87991677 |
| 50 | Atrioventricular block (HP:0001678) | 2.87807327 |
| 51 | Atonic seizures (HP:0010819) | 2.85239893 |
| 52 | Abnormal EKG (HP:0003115) | 2.83040916 |
| 53 | Intention tremor (HP:0002080) | 2.78075279 |
| 54 | Papilledema (HP:0001085) | 2.75867617 |
| 55 | Polygenic inheritance (HP:0010982) | 2.71825295 |
| 56 | Abnormality of midbrain morphology (HP:0002418) | 2.68077360 |
| 57 | Molar tooth sign on MRI (HP:0002419) | 2.68077360 |
| 58 | Spastic gait (HP:0002064) | 2.67956143 |
| 59 | Abnormal eating behavior (HP:0100738) | 2.66678744 |
| 60 | Abnormality of oral frenula (HP:0000190) | 2.65993737 |
| 61 | Aplasia/Hypoplasia of the tibia (HP:0005772) | 2.65790204 |
| 62 | Abnormality of the ischium (HP:0003174) | 2.65746176 |
| 63 | Impaired vibratory sensation (HP:0002495) | 2.65630172 |
| 64 | Aplasia/Hypoplasia affecting the retina (HP:0008061) | 2.63710162 |
| 65 | Limb dystonia (HP:0002451) | 2.60171008 |
| 66 | Hyperventilation (HP:0002883) | 2.58847463 |
| 67 | Nephronophthisis (HP:0000090) | 2.57844479 |
| 68 | Albinism (HP:0001022) | 2.54647320 |
| 69 | Supranuclear gaze palsy (HP:0000605) | 2.50668028 |
| 70 | Limb hypertonia (HP:0002509) | 2.49326941 |
| 71 | Aplasia/Hypoplasia of the pubic bone (HP:0009104) | 2.48535276 |
| 72 | Abnormality of ocular smooth pursuit (HP:0000617) | 2.47646117 |
| 73 | Megalencephaly (HP:0001355) | 2.47585802 |
| 74 | Bradykinesia (HP:0002067) | 2.45862263 |
| 75 | Decreased central vision (HP:0007663) | 2.40744892 |
| 76 | Cerebellar dysplasia (HP:0007033) | 2.40220282 |
| 77 | Distal lower limb amyotrophy (HP:0008944) | 2.39220492 |
| 78 | Clonus (HP:0002169) | 2.37212779 |
| 79 | Amblyopia (HP:0000646) | 2.37085948 |
| 80 | Heart block (HP:0012722) | 2.36533803 |
| 81 | Attenuation of retinal blood vessels (HP:0007843) | 2.34923397 |
| 82 | Short 4th metacarpal (HP:0010044) | 2.34651427 |
| 83 | Aplasia/Hypoplasia of the 4th metacarpal (HP:0010042) | 2.34651427 |
| 84 | Rib fusion (HP:0000902) | 2.33858631 |
| 85 | Retinal dysplasia (HP:0007973) | 2.32815764 |
| 86 | Hypoplastic ischia (HP:0003175) | 2.32413164 |
| 87 | Type II lissencephaly (HP:0007260) | 2.31898497 |
| 88 | Incomplete penetrance (HP:0003829) | 2.28918284 |
| 89 | Abnormality of the lower motor neuron (HP:0002366) | 2.26026895 |
| 90 | Abnormality of the renal medulla (HP:0100957) | 2.22048443 |
| 91 | Renal cortical cysts (HP:0000803) | 2.21961779 |
| 92 | Abnormality of the renal cortex (HP:0011035) | 2.19025199 |
| 93 | Chronic hepatic failure (HP:0100626) | 2.16928899 |
| 94 | Insidious onset (HP:0003587) | 2.15268031 |
| 95 | Termporal pattern (HP:0011008) | 2.15268031 |
| 96 | Aplasia/Hypoplasia affecting the fundus (HP:0008057) | 2.15002679 |
| 97 | Abnormal atrioventricular conduction (HP:0005150) | 2.14992006 |
| 98 | Hemiparesis (HP:0001269) | 2.14979630 |
| 99 | Optic nerve hypoplasia (HP:0000609) | 2.14727556 |
| 100 | Midline defect of the nose (HP:0004122) | 2.14675441 |
| 101 | Pancreatic fibrosis (HP:0100732) | 2.14461547 |
| 102 | Lower limb muscle weakness (HP:0007340) | 2.13611904 |
| 103 | Abnormality of saccadic eye movements (HP:0000570) | 2.13587707 |
| 104 | Intestinal atresia (HP:0011100) | 2.13178854 |
| 105 | Mutism (HP:0002300) | 2.12805565 |
| 106 | Preaxial foot polydactyly (HP:0001841) | 2.12130953 |
| 107 | True hermaphroditism (HP:0010459) | 2.11526571 |
| 108 | Epileptiform EEG discharges (HP:0011182) | 2.09805420 |
| 109 | Progressive inability to walk (HP:0002505) | 2.08757325 |
| 110 | Cutaneous finger syndactyly (HP:0010554) | 2.08728801 |
| 111 | Genetic anticipation (HP:0003743) | 2.07984980 |
| 112 | EEG with generalized epileptiform discharges (HP:0011198) | 2.05725665 |
| 113 | Pancreatic cysts (HP:0001737) | 2.05423569 |
| 114 | Proximal tubulopathy (HP:0000114) | 2.03376363 |
| 115 | Status epilepticus (HP:0002133) | 2.02734905 |
| 116 | Abnormality of the 4th metacarpal (HP:0010012) | 2.02336940 |
| 117 | Drooling (HP:0002307) | 2.02115210 |
| 118 | Excessive salivation (HP:0003781) | 2.02115210 |
| 119 | Distal upper limb amyotrophy (HP:0007149) | 2.01982843 |
| 120 | Upper limb amyotrophy (HP:0009129) | 2.01982843 |
| 121 | Hypsarrhythmia (HP:0002521) | 2.01792400 |
| 122 | Pachygyria (HP:0001302) | 2.00672383 |
| 123 | Ventricular fibrillation (HP:0001663) | 2.00186336 |
| 124 | Hemiplegia (HP:0002301) | 1.99926335 |
| 125 | Short tibia (HP:0005736) | 1.99589147 |
| 126 | Abnormality of the pubic bones (HP:0003172) | 1.99114278 |
| 127 | Lower limb asymmetry (HP:0100559) | 1.97831184 |
| 128 | Truncus arteriosus (HP:0001660) | 1.97801837 |
| 129 | Primary atrial arrhythmia (HP:0001692) | 1.97233169 |
| 130 | Polydipsia (HP:0001959) | 1.96531061 |
| 131 | Abnormal drinking behavior (HP:0030082) | 1.96531061 |
| 132 | Atrial fibrillation (HP:0005110) | 1.94880503 |
| 133 | Bifid tongue (HP:0010297) | 1.94082282 |
| 134 | Tubulointerstitial nephritis (HP:0001970) | 1.93363636 |
| 135 | Fetal akinesia sequence (HP:0001989) | 1.92977256 |
| 136 | Bony spicule pigmentary retinopathy (HP:0007737) | 1.92426380 |
| 137 | Obsessive-compulsive behavior (HP:0000722) | 1.91041244 |
| 138 | Bowel incontinence (HP:0002607) | 1.90688604 |
| 139 | Neuronal loss in central nervous system (HP:0002529) | 1.88787526 |
| 140 | Neurofibrillary tangles (HP:0002185) | 1.86675640 |
| 141 | Tubular atrophy (HP:0000092) | 1.86669456 |
| 142 | Gait ataxia (HP:0002066) | 1.86355182 |
| 143 | Lissencephaly (HP:0001339) | 1.85352221 |
| 144 | Abnormality of the periventricular white matter (HP:0002518) | 1.85297802 |
| 145 | Anophthalmia (HP:0000528) | 1.85081781 |
| 146 | Increased corneal curvature (HP:0100692) | 1.84914040 |
| 147 | Keratoconus (HP:0000563) | 1.84914040 |
| 148 | Chorioretinal atrophy (HP:0000533) | 1.84810865 |
| 149 | Obstructive sleep apnea (HP:0002870) | 1.84803316 |
| 150 | Onion bulb formation (HP:0003383) | 1.83866157 |
| 151 | Sclerocornea (HP:0000647) | 1.83648970 |
| 152 | Aplasia/Hypoplasia of the optic nerve (HP:0008058) | 1.83302577 |
| 153 | Supraventricular tachycardia (HP:0004755) | 1.82768333 |
| 154 | Spinal canal stenosis (HP:0003416) | 1.81746378 |
| 155 | Oligodactyly (hands) (HP:0001180) | 1.80549618 |
| 156 | Blue irides (HP:0000635) | 1.78568554 |
| 157 | Bundle branch block (HP:0011710) | 1.77249934 |
| 158 | Dysphonia (HP:0001618) | 1.77018730 |
| 159 | Supraventricular arrhythmia (HP:0005115) | 1.76085204 |
| 160 | Astigmatism (HP:0000483) | 1.71508537 |
| 161 | Acute lymphatic leukemia (HP:0006721) | 1.70756714 |
| 162 | Medial flaring of the eyebrow (HP:0010747) | 1.70102868 |
| 163 | Genital tract atresia (HP:0001827) | 1.69919774 |
| 164 | Patellar aplasia (HP:0006443) | 1.69620138 |
| 165 | Gait imbalance (HP:0002141) | 1.68010345 |
| 166 | Median cleft lip (HP:0000161) | 1.67226949 |
| 167 | Protruding tongue (HP:0010808) | 1.67126234 |
| 168 | Preaxial hand polydactyly (HP:0001177) | 1.66393495 |
| 169 | Vaginal atresia (HP:0000148) | 1.65942928 |
| 170 | Partial agenesis of the corpus callosum (HP:0001338) | 1.65669672 |
| 171 | Abnormality of the aortic arch (HP:0012303) | 1.65617999 |
| 172 | Cutaneous syndactyly (HP:0012725) | 1.62957972 |
| 173 | Inability to walk (HP:0002540) | 1.61270355 |
| 174 | Small hand (HP:0200055) | 1.61260073 |
| 175 | Highly arched eyebrow (HP:0002553) | 1.61058770 |
| 176 | Aplasia/Hypoplasia of the lens (HP:0008063) | 1.58438378 |
| 177 | Absent speech (HP:0001344) | 1.57599909 |
| 178 | Bilateral microphthalmos (HP:0007633) | 1.56954588 |
| 179 | Postaxial hand polydactyly (HP:0001162) | 1.56301220 |
| 180 | Cystic liver disease (HP:0006706) | 1.56253358 |
| 181 | Aplasia/Hypoplasia of the patella (HP:0006498) | 1.52527396 |
| 182 | Morphological abnormality of the middle ear (HP:0008609) | 1.52321838 |
| 183 | Renal hypoplasia (HP:0000089) | 1.52100967 |
| 184 | Abnormality of the labia minora (HP:0012880) | 1.51267914 |
| 185 | Exotropia (HP:0000577) | 1.50123916 |
| 186 | Ectopic kidney (HP:0000086) | 1.49144709 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | EPHA4 | 7.97178350 |
| 2 | FRK | 4.55764723 |
| 3 | NTRK3 | 4.18823889 |
| 4 | MAP3K9 | 3.18308354 |
| 5 | BRD4 | 3.01515185 |
| 6 | DAPK2 | 2.84137617 |
| 7 | RIPK4 | 2.71632351 |
| 8 | PRKD3 | 2.62529479 |
| 9 | KSR2 | 2.54829913 |
| 10 | PNCK | 2.54082260 |
| 11 | CAMKK1 | 2.49364663 |
| 12 | INSRR | 2.26032645 |
| 13 | NTRK1 | 2.16800820 |
| 14 | MINK1 | 2.15662812 |
| 15 | NTRK2 | 2.09918886 |
| 16 | MARK1 | 2.07974892 |
| 17 | MAP4K2 | 2.01854647 |
| 18 | CAMKK2 | 1.97602969 |
| 19 | MAP3K4 | 1.95453248 |
| 20 | FES | 1.93409740 |
| 21 | KSR1 | 1.77369444 |
| 22 | BMPR1B | 1.76599749 |
| 23 | STK39 | 1.72086756 |
| 24 | TAOK1 | 1.68834664 |
| 25 | TNIK | 1.66906265 |
| 26 | CDK5 | 1.59347813 |
| 27 | WNK4 | 1.57461601 |
| 28 | ACVR1B | 1.55657455 |
| 29 | MAP3K13 | 1.54594334 |
| 30 | DAPK1 | 1.53282463 |
| 31 | MAP3K2 | 1.52904313 |
| 32 | PAK6 | 1.51350838 |
| 33 | STK38L | 1.50061329 |
| 34 | ARAF | 1.49072751 |
| 35 | EPHB2 | 1.47088404 |
| 36 | CSNK1A1L | 1.41720841 |
| 37 | CAMK1G | 1.40204044 |
| 38 | MAP2K7 | 1.38913496 |
| 39 | ADRBK2 | 1.36885223 |
| 40 | SIK2 | 1.35308019 |
| 41 | TYRO3 | 1.33502359 |
| 42 | GRK1 | 1.25096612 |
| 43 | MKNK2 | 1.24570377 |
| 44 | PAK3 | 1.23773839 |
| 45 | PRPF4B | 1.18191312 |
| 46 | CSNK1G1 | 1.17735597 |
| 47 | SGK223 | 1.16882016 |
| 48 | SGK494 | 1.16882016 |
| 49 | AKT3 | 1.14226512 |
| 50 | LATS1 | 1.13452007 |
| 51 | CSNK1G3 | 1.12754868 |
| 52 | OXSR1 | 1.12501589 |
| 53 | SGK2 | 1.11518723 |
| 54 | RAF1 | 1.11090992 |
| 55 | BMPR2 | 1.10362881 |
| 56 | MET | 1.09570517 |
| 57 | MAP2K4 | 1.08414983 |
| 58 | DYRK2 | 1.06847386 |
| 59 | ZAK | 1.06048495 |
| 60 | SGK3 | 1.00559372 |
| 61 | PRKCH | 0.99851173 |
| 62 | STK38 | 0.96855251 |
| 63 | MAPK15 | 0.96335423 |
| 64 | PINK1 | 0.95221657 |
| 65 | MARK2 | 0.94845719 |
| 66 | ERBB3 | 0.94007120 |
| 67 | TIE1 | 0.93647808 |
| 68 | PLK4 | 0.93464862 |
| 69 | BCR | 0.92658023 |
| 70 | RIPK1 | 0.90577515 |
| 71 | SGK1 | 0.87731600 |
| 72 | MAPK13 | 0.86668374 |
| 73 | STK11 | 0.84549598 |
| 74 | PRKCG | 0.84535772 |
| 75 | CDK12 | 0.83037142 |
| 76 | RET | 0.82847668 |
| 77 | UHMK1 | 0.80967793 |
| 78 | DDR2 | 0.80003576 |
| 79 | CAMK2A | 0.79417030 |
| 80 | MKNK1 | 0.78881960 |
| 81 | CAMK2B | 0.78569984 |
| 82 | PDPK1 | 0.77039536 |
| 83 | CAMK1D | 0.76911751 |
| 84 | CDK18 | 0.76217297 |
| 85 | CDK15 | 0.74080166 |
| 86 | PKN1 | 0.72605563 |
| 87 | CAMK1 | 0.71588292 |
| 88 | PDK1 | 0.70977158 |
| 89 | LATS2 | 0.70815681 |
| 90 | CDK14 | 0.69797213 |
| 91 | MAP3K1 | 0.68819147 |
| 92 | PTK2B | 0.68549395 |
| 93 | NEK6 | 0.68275140 |
| 94 | EPHA3 | 0.67172672 |
| 95 | CASK | 0.64672643 |
| 96 | CDK11A | 0.62813406 |
| 97 | ALK | 0.62442244 |
| 98 | MAP2K1 | 0.62363110 |
| 99 | ADRBK1 | 0.61719370 |
| 100 | WEE1 | 0.61520263 |
| 101 | NEK1 | 0.60505663 |
| 102 | TGFBR1 | 0.59586465 |
| 103 | RPS6KA3 | 0.58151343 |
| 104 | FYN | 0.56648851 |
| 105 | MUSK | 0.55740721 |
| 106 | PRKCZ | 0.55388656 |
| 107 | TNK2 | 0.54513981 |
| 108 | TRIB3 | 0.54087858 |
| 109 | WNK1 | 0.53511666 |
| 110 | CAMK4 | 0.53336724 |
| 111 | LMTK2 | 0.53234108 |
| 112 | ROCK1 | 0.52302563 |
| 113 | MAPKAPK5 | 0.51780133 |
| 114 | PRKD2 | 0.51693157 |
| 115 | SCYL2 | 0.51248800 |
| 116 | MAP3K12 | 0.51051205 |
| 117 | GRK5 | 0.49602026 |
| 118 | MAPK10 | 0.49152242 |
| 119 | TLK1 | 0.48987676 |
| 120 | DMPK | 0.48175318 |
| 121 | MAPK7 | 0.47480104 |
| 122 | PHKG1 | 0.47257046 |
| 123 | PHKG2 | 0.47257046 |
| 124 | PRKG1 | 0.46413041 |
| 125 | CDK3 | 0.46250118 |
| 126 | PRKAA1 | 0.46191296 |
| 127 | BRSK1 | 0.45879889 |
| 128 | DAPK3 | 0.45254324 |
| 129 | CSNK1D | 0.44923196 |
| 130 | NUAK1 | 0.44388724 |
| 131 | CSNK1E | 0.43946221 |
| 132 | DYRK3 | 0.43729370 |
| 133 | NEK2 | 0.41998561 |
| 134 | MAP3K7 | 0.41587746 |
| 135 | BRSK2 | 0.41418568 |
| 136 | RPS6KB1 | 0.41157001 |
| 137 | TRPM7 | 0.41032266 |
| 138 | PRKCB | 0.39183824 |
| 139 | FGFR2 | 0.39164403 |
| 140 | NME1 | 0.38943110 |
| 141 | PRKCE | 0.38675567 |
| 142 | CAMK2D | 0.38248363 |
| 143 | PLK2 | 0.37415349 |
| 144 | CDC42BPA | 0.37154319 |
| 145 | PDGFRA | 0.36804670 |
| 146 | CAMK2G | 0.35486353 |
| 147 | BRAF | 0.35271406 |
| 148 | CSNK1G2 | 0.32691669 |
| 149 | RPS6KA2 | 0.32169531 |
| 150 | PRKACG | 0.30922883 |
| 151 | CSNK1A1 | 0.30264037 |
| 152 | WNK3 | 0.29597869 |
| 153 | MOS | 0.29430397 |
| 154 | * PRKACA | 0.28592721 |
| 155 | MAPK8 | 0.27635484 |
| 156 | HCK | 0.26485465 |
| 157 | PRKCA | 0.26061401 |
| 158 | DYRK1A | 0.25868120 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Olfactory transduction_Homo sapiens_hsa04740 | 3.79421171 |
| 2 | Nicotine addiction_Homo sapiens_hsa05033 | 2.86842451 |
| 3 | Circadian entrainment_Homo sapiens_hsa04713 | 2.86252237 |
| 4 | Amphetamine addiction_Homo sapiens_hsa05031 | 2.83388364 |
| 5 | * Morphine addiction_Homo sapiens_hsa05032 | 2.82741870 |
| 6 | Cocaine addiction_Homo sapiens_hsa05030 | 2.82575263 |
| 7 | GABAergic synapse_Homo sapiens_hsa04727 | 2.72004617 |
| 8 | Long-term potentiation_Homo sapiens_hsa04720 | 2.65439044 |
| 9 | Glutamatergic synapse_Homo sapiens_hsa04724 | 2.57220043 |
| 10 | Dopaminergic synapse_Homo sapiens_hsa04728 | 2.50778589 |
| 11 | Retrograde endocannabinoid signaling_Homo sapiens_hsa04723 | 2.42985991 |
| 12 | Synaptic vesicle cycle_Homo sapiens_hsa04721 | 2.42486144 |
| 13 | Cholinergic synapse_Homo sapiens_hsa04725 | 2.33063622 |
| 14 | Renin secretion_Homo sapiens_hsa04924 | 2.13646316 |
| 15 | Salivary secretion_Homo sapiens_hsa04970 | 2.10275212 |
| 16 | Aldosterone synthesis and secretion_Homo sapiens_hsa04925 | 1.99103528 |
| 17 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 1.94464599 |
| 18 | Oxytocin signaling pathway_Homo sapiens_hsa04921 | 1.78242858 |
| 19 | Insulin secretion_Homo sapiens_hsa04911 | 1.77805696 |
| 20 | Gastric acid secretion_Homo sapiens_hsa04971 | 1.76915007 |
| 21 | Calcium signaling pathway_Homo sapiens_hsa04020 | 1.75666166 |
| 22 | Gap junction_Homo sapiens_hsa04540 | 1.72076990 |
| 23 | Adrenergic signaling in cardiomyocytes_Homo sapiens_hsa04261 | 1.71809936 |
| 24 | Endocrine and other factor-regulated calcium reabsorption_Homo sapiens_hsa04961 | 1.71142772 |
| 25 | Serotonergic synapse_Homo sapiens_hsa04726 | 1.65031707 |
| 26 | Long-term depression_Homo sapiens_hsa04730 | 1.58794706 |
| 27 | Hedgehog signaling pathway_Homo sapiens_hsa04340 | 1.57673895 |
| 28 | Nitrogen metabolism_Homo sapiens_hsa00910 | 1.53620079 |
| 29 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 1.50766294 |
| 30 | Taste transduction_Homo sapiens_hsa04742 | 1.47720184 |
| 31 | GnRH signaling pathway_Homo sapiens_hsa04912 | 1.46375500 |
| 32 | cAMP signaling pathway_Homo sapiens_hsa04024 | 1.42787292 |
| 33 | Basal cell carcinoma_Homo sapiens_hsa05217 | 1.41693993 |
| 34 | Selenocompound metabolism_Homo sapiens_hsa00450 | 1.35389618 |
| 35 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 1.30538078 |
| 36 | Hippo signaling pathway_Homo sapiens_hsa04390 | 1.25961305 |
| 37 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 1.18406299 |
| 38 | Glioma_Homo sapiens_hsa05214 | 1.17780451 |
| 39 | Lysine degradation_Homo sapiens_hsa00310 | 1.16470054 |
| 40 | Aldosterone-regulated sodium reabsorption_Homo sapiens_hsa04960 | 1.15281861 |
| 41 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 1.13288048 |
| 42 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 1.12221381 |
| 43 | Estrogen signaling pathway_Homo sapiens_hsa04915 | 1.10746784 |
| 44 | cGMP-PKG signaling pathway_Homo sapiens_hsa04022 | 1.09878318 |
| 45 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 1.08881404 |
| 46 | Vascular smooth muscle contraction_Homo sapiens_hsa04270 | 1.08775823 |
| 47 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 1.07332390 |
| 48 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 1.05780212 |
| 49 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 1.04501595 |
| 50 | Glycosylphosphatidylinositol(GPI)-anchor biosynthesis_Homo sapiens_hsa00563 | 1.01212442 |
| 51 | Ether lipid metabolism_Homo sapiens_hsa00565 | 1.00320666 |
| 52 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 1.00187637 |
| 53 | Neuroactive ligand-receptor interaction_Homo sapiens_hsa04080 | 0.98389311 |
| 54 | Alcoholism_Homo sapiens_hsa05034 | 0.97793169 |
| 55 | Vasopressin-regulated water reabsorption_Homo sapiens_hsa04962 | 0.95880577 |
| 56 | Melanogenesis_Homo sapiens_hsa04916 | 0.94953113 |
| 57 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 0.94383384 |
| 58 | Fanconi anemia pathway_Homo sapiens_hsa03460 | 0.93586981 |
| 59 | ErbB signaling pathway_Homo sapiens_hsa04012 | 0.92367577 |
| 60 | TGF-beta signaling pathway_Homo sapiens_hsa04350 | 0.90778533 |
| 61 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 0.90559595 |
| 62 | Phototransduction_Homo sapiens_hsa04744 | 0.89351117 |
| 63 | Signaling pathways regulating pluripotency of stem cells_Homo sapiens_hsa04550 | 0.89311412 |
| 64 | Mucin type O-Glycan biosynthesis_Homo sapiens_hsa00512 | 0.86177618 |
| 65 | Axon guidance_Homo sapiens_hsa04360 | 0.85052690 |
| 66 | Oocyte meiosis_Homo sapiens_hsa04114 | 0.84950247 |
| 67 | Basal transcription factors_Homo sapiens_hsa03022 | 0.83993671 |
| 68 | Dilated cardiomyopathy_Homo sapiens_hsa05414 | 0.83472643 |
| 69 | Pancreatic secretion_Homo sapiens_hsa04972 | 0.81318205 |
| 70 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 0.81296275 |
| 71 | Rap1 signaling pathway_Homo sapiens_hsa04015 | 0.80326354 |
| 72 | Thyroid hormone synthesis_Homo sapiens_hsa04918 | 0.77215344 |
| 73 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 0.77119109 |
| 74 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 0.76712538 |
| 75 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 0.75400893 |
| 76 | Glycosaminoglycan biosynthesis - heparan sulfate / heparin_Homo sapiens_hsa00534 | 0.74217438 |
| 77 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.73877843 |
| 78 | ECM-receptor interaction_Homo sapiens_hsa04512 | 0.72388367 |
| 79 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.72292960 |
| 80 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.69550397 |
| 81 | Tryptophan metabolism_Homo sapiens_hsa00380 | 0.67903307 |
| 82 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.67523310 |
| 83 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 0.66545463 |
| 84 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.66484872 |
| 85 | ABC transporters_Homo sapiens_hsa02010 | 0.66110057 |
| 86 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 0.65209222 |
| 87 | Thyroid hormone signaling pathway_Homo sapiens_hsa04919 | 0.64015429 |
| 88 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 0.63226118 |
| 89 | Cardiac muscle contraction_Homo sapiens_hsa04260 | 0.62908141 |
| 90 | Protein digestion and absorption_Homo sapiens_hsa04974 | 0.61631874 |
| 91 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.60773762 |
| 92 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 0.60182131 |
| 93 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 0.59894656 |
| 94 | Tight junction_Homo sapiens_hsa04530 | 0.59713858 |
| 95 | mTOR signaling pathway_Homo sapiens_hsa04150 | 0.58916359 |
| 96 | Longevity regulating pathway - mammal_Homo sapiens_hsa04211 | 0.57712477 |
| 97 | Ras signaling pathway_Homo sapiens_hsa04014 | 0.55233512 |
| 98 | Bile secretion_Homo sapiens_hsa04976 | 0.55063004 |
| 99 | Homologous recombination_Homo sapiens_hsa03440 | 0.53691294 |
| 100 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 0.52349449 |
| 101 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.51966914 |
| 102 | Terpenoid backbone biosynthesis_Homo sapiens_hsa00900 | 0.51822269 |
| 103 | Longevity regulating pathway - multiple species_Homo sapiens_hsa04213 | 0.51142579 |
| 104 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.50056782 |
| 105 | Endometrial cancer_Homo sapiens_hsa05213 | 0.49986201 |
| 106 | Platelet activation_Homo sapiens_hsa04611 | 0.49427293 |
| 107 | Arrhythmogenic right ventricular cardiomyopathy (ARVC)_Homo sapiens_hsa05412 | 0.49030770 |
| 108 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 0.48882161 |
| 109 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 0.48659796 |
| 110 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 0.47717999 |
| 111 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.46526234 |
| 112 | Other types of O-glycan biosynthesis_Homo sapiens_hsa00514 | 0.46374753 |
| 113 | Alzheimers disease_Homo sapiens_hsa05010 | 0.45842206 |
| 114 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | 0.44309834 |
| 115 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.43538763 |
| 116 | Endocytosis_Homo sapiens_hsa04144 | 0.43043201 |
| 117 | Circadian rhythm_Homo sapiens_hsa04710 | 0.42599585 |
| 118 | Prion diseases_Homo sapiens_hsa05020 | 0.41797392 |
| 119 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 0.40478250 |
| 120 | African trypanosomiasis_Homo sapiens_hsa05143 | 0.40337488 |
| 121 | Retinol metabolism_Homo sapiens_hsa00830 | 0.40010650 |
| 122 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 0.38289835 |
| 123 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 0.37863628 |
| 124 | Progesterone-mediated oocyte maturation_Homo sapiens_hsa04914 | 0.37700521 |
| 125 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.37396193 |
| 126 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 0.36935169 |
| 127 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 0.36784787 |
| 128 | Thyroid cancer_Homo sapiens_hsa05216 | 0.36130801 |
| 129 | Insulin signaling pathway_Homo sapiens_hsa04910 | 0.35674889 |
| 130 | Histidine metabolism_Homo sapiens_hsa00340 | 0.34570298 |
| 131 | Regulation of autophagy_Homo sapiens_hsa04140 | 0.34098044 |
| 132 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.32552848 |
| 133 | Hypertrophic cardiomyopathy (HCM)_Homo sapiens_hsa05410 | 0.32377421 |
| 134 | Huntingtons disease_Homo sapiens_hsa05016 | 0.31968250 |
| 135 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.29804697 |
| 136 | Butanoate metabolism_Homo sapiens_hsa00650 | 0.28609061 |
| 137 | Arginine biosynthesis_Homo sapiens_hsa00220 | 0.27265400 |
| 138 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.24442267 |
| 139 | Wnt signaling pathway_Homo sapiens_hsa04310 | 0.23589708 |

